BioSpace News Archive

Directive mandates reimbursement coverage of Tumor Treating Fields for patients with newly diagnosed glioblastoma by the compulsory health insurance system

Specialty diagnostics company Precipio, Inc., released the following letter to shareholders from its CEO, Ilan Danieli.

Infiniti Research is the world’s leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed to connect your organization’s goals with global opportunities. Today’s international business environment demands in-depth, accurate, and reliable local business information to ensure that global companies gain a strong foothold in foreign markets. Our global industry specialist t

Virologist and biological defense specialist, Dr. Steven Hatfill, educates the American people as a public service to the world.

Application works with electronic health records to track patient medical tests; helps with coronavirus patient workflows

The “Beijing Expert Consensus Statement on the Standardized Application of Next-Generation Sequencing Technology in Clinical Tests - Tumor (1st Edition)” has been officially published in Chinese Medical Journal

Pharmacy organizations representing the interests of all pharmacists in the United States have released a joint set of policy recommendations critical to addressing the COVID-19 pandemic.

New services will reduce burden on hospitals by enabling home health care agencies to serve 14,500 patients dail

Molecular diagnostics company Lucence announced today the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to facilitate more accessible testing of viral infections such as COVID-19. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200320005151/en/ Genomics Company Luce